OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites
Clinical trial NCT06856603 · RECRUITING
Trial details
- NCT number
- NCT06856603
- Sponsor
- National Medical Research Radiological Centre of the Ministry of Health of Russia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2027-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.